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ABSTRACT
Holmes, Benjamin Andrew. M.S. Microbiology and Immunology, Wright State
University, 2012. The construction of a plasmid for detecting the pathway of arginine
metabolism in human macrophages: real-time assessment of macrophage polarity.

Macrophages are “first responders”, innate immune system cells which quickly arrive to a
site of infection and injury, consuming cell debris and foreign matter and recruiting other
immune system cells to the area. While historically they have been thought to react uniformly to
all challenges, the discovery of toll-like receptors has shown that macrophages actually work
closely with the adaptive immune system in fine-tuning the immune response. Furthermore, it
has recently been discovered that macrophages can become polarized to one of two subtypes –
M1 or M2.

M1 macrophages are efficient producers of reactive oxygen species, nitrogen
intermediates, and inflammatory cytokines. They are especially effective at mediating
resistance against intracellular parasites and tumors. Arginine metabolism in M1
macrophages is characterized by high levels of inducible nitric oxide synthetase (iNos),
and this is used as a marker for polarization of macrophages to the M1 phenotype. M2
macrophages, by contrast, produce anti-inflammatory molecules, have high levels of
scavenger, mannose, and galactose-type receptors, and arginine metabolism is shifted
to production of ornithine and polyamines via arginase. Arginase, encoded by the ARG1
gene, is considered to be one of the hallmarks of the M2 phenotype, and is one of the
most specific markers used to determine polarization to that phenotype.
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Polarization to one phenotype or another is not permanent, and macrophages can
be polarized directly from one state to the other directly by addition of appropriate
cytokines (IFNy, LPS, TNFa for M1, IL-4, IL-13, IL-10, TGFb for M2). The state of
macrophage polarization can be determined by examining a population of macrophages
for tell-tale products of one state or another (ROS, RNS, TNFa, IL-1, IL-6, IL-12, or IL-23
for M1, IL-10, TGFb, PDGF, VEGF, EGF, and arginase for M2). Determining macrophage
polarization has implications in health outcomes- M1 macrophages excel at fighting
parasites and fighting tumorous growth, while M2 macrophages assist in wound healing
and nerve re-growth. The problem is that the methods of detecting macrophage
polarization – flow cytometry, western blots, or ELISA tests, are not real time and kill the
cells involved. This paper describes the theory and methods behind creating a plasmid
which combines the promoter for genes whose transcription indicates the M1 or M2
phenotype with a GFP or RFP, when transfected into a colony of RAW macrophages, will
enable realtime, quantitative visualization of the production of inducible nitric oxide
synthetase or arginase, markers for the M1 and M2 phenotype. A clearer understanding
of macrophage polarity in the course of illness, wounding, and cancer might lead to
diagnostic or therapeutic discoveries in those areas.
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INTRODUCTION AND PURPOSE
Traditionally, macrophages have been thought of as “first responders”, members
of the innate immune system that serve the body both by engulfing and processing
foreign threats when possible, and by helping to direct the rest of the immune system in
combatting threats (Gordon, 1999). One way the macrophage helps direct the immune
system is by secreting pro-inflammatory and antimicrobial mediators. It is known that,
through toll-like receptors, macrophages can be made to secrete cytokines that induce or
repress inflammation, recruit other immune system cells, and prime elements of the
adaptive immune response for a fine-tuned response (Stein et al., 1992).

Fig. 1: Macrophages have an important role in the immune system – they modify and direct both the innate and
adaptive immune system, through antigen presentation and TLRs. Adapted from Scott-Algara et al., 2008
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Nevertheless, it was previously thought that macrophages existed as essentially singlephenotype antigen-presenting cells which played a role in the development of the
immune response through the secretion of various cytokines (Gordon, 1999).
Today, these macrophages are known to be “classically activated”, or M1
macrophages. In order to become classically activated, macrophages require priming with
interferon gamma (IFN- γ) (Dalton, 1993), by way of the IFN-γ receptor (Huang, 1993),
or through lipopolysaccharide (LPS). When a macrophage thus primed by IFN-γ or LPS
encounters a recognized stimulus, for example a bacterial product, it initiates classical
activation. If the macrophage encounters LPS, the LPS is bound by soluble
lipopolysaccharide-binding protein (LBP) and then by CD14, which can be either soluble
or membrane-bound. CD14 delivers LPS to the LPS recognition complex (Janeway and
Medzhitov, 2002), TLR4 and MD-2. (Nagai et al., 2002) The foreign pathogens and their
components are subsequently taken up by phagocytosis (Greenberg and Grinstein, 2002).
Once inside the macrophage, they are delivered to lysosomes where they are degraded by
a variety of enzymes, such as cathepsin cysteine proteases. (Honey and Rudensky, 2003).
Once degraded by enzymes, the antigens are processed and loaded onto MHC class II
molecules. On the surface of the macrophage, late endocytic compartments and
antigen/MHC class II complexes are presented to T cells, along with co-stimulatory B7
family members (Harding, 2003)
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Fig. 2: Antigen presenting cells, like macrophages, serve a vital role in stimulating the proliferation of T cells, here
shown presenting their antigens to T cells along with costimulatory B7 molecules. Adapted from Zou and Chen, 2008

Once classically activated, the macrophage undergoes significant changes in its
morphology and in the content of molecules secreted from the cell. To attract neutrophils
and limit angiogenesis, C-X-C- Motif protein 8 (CXCL8) is released. CXCL10,
Chemokine (C-C-motif) ligand 3 (CCL3), and CCL4, chemoattractants for
polymorphonuclear leukocyotes and natural killer cells, and CCL5, a chemokine for Tcells, eosinophils, and basophils, are also produced, (Luster, 2002) along with cytokines
designed to promote inflammation, such as IL-1 β/IL-1F2, IL-6, and TNF-α/TNFSF1A.
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(Duffield, 2003, Gordan, 2003, Ma et al., 2003, Mosser, 2003). In addition to being
proinflammatory, TNF-α is a prophagocytic agent for the macrophage (Boyle et al., 2003,
Duffield et al., 2001, Song et al., 2000). Other hallmarks of classical activation are nitric
oxide release as a result of inducible nitric oxide synthase (iNOS) upregulation (Hesse et
al., 2001, Thomassen and Karvau, 2001, Duffield et al., 2000, Munder et al., 1998), and
Fas Ligand/TNFSF6 secretion (Boyle et al., 2003). Proteolytic enzymes are also released
by the classically activated macrophage; these include MMP (matrix metalloproteinase)1, -2, -7, -9, and -12, which degrade extracellular matrix (ECM) components such as
collagen, elastin, and fibronectin (Chizzolini et al., 2000, Gibbs et al., 1999 (1), Gibbs et
al., 1999 (2)).

Fig. 3: Elastic, collagen, and Gelatin can all be degraded with the use of MMPs, shown here released by a classically
activated macrophage. Adapted from Elkington and Friedland, 2006
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The release of these molecules is both a boon and a potential hazard. They are
important for the protection of the host, and also help to direct the course of the innate
and adaptive immune response. However, they also have the potential to cause significant
damage to the local host environment. These cytokines are designed to cause infiltration
by other leukocytes, and can do so on a massive scale. These invading leukocytes and the
classically activated macrophages themselves can flood the area with pro-apoptotic and
pro-inflammatory factors, and matrix degrading proteases. In this way, M1 macrophages
can disrupt tissue structure, to the point of causing serious damage. Not only are there the
obvious short-term negative consequences of this issue destruction, but tissue destruction
caused by chronic inflammation has been associated with more long-term negative
effects, including the development of tumors, type 1 autoimmune diseases, and
glomerulonephritis (Gordon, 2003, Ma et al., 2003, Mosser, 2003).

Fig. 4: Macrophage accumulation is a prominent feature in most types of human glomerulonephritis: here
macrophages, stained brown, are shown in the kidney. Adapted from Busey et al., 2012
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The understanding about macrophage states was broadened in 1993 in the seminal
paper by Stein, Keshav, Harris, and Gordon. This paper was the first to describe
macrophages having a phenotype different from the “classically” activated macrophage.
They noted that when stimulated with IL4, macrophages would display relatively few
characteristics commonly found in classically activated cells (up-regulation of
proinflammatory cytokines, recruitment of other immune system cells to the area), but
did display the upregulation of the macrophage mannose receptor (MRC1), otherwise
known as CD206, as measured by the binding and degradation of I-mannose-bovine
serum albumin. They performed PCR analysis of cDNA from purified primary
macrophage populations to confirm that the macrophage mannose receptor, but not
lysozyme or tumor necrosis factor alpha levels were increased.

Fig. 5: The two types of macrophage polarization can lead to differing health outcomes, as shown here relating to
inflammation. Adapted from Tidball, 2011
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Macrophages taken from wild-type mice in vitro or in vivo, would develop this
alternate activation when a TH2 response was induced by challenge with Schistosoma
mansoni eggs. However, in a knockdown strain of mice, that was -/- for IL-4R , the
common α receptor chain for IL-4 and IL-13 (Th2 cytokines), a similar challenge would
elicit a classically activated or Th1-type response, not the Th2 response. The mannose
receptor was expressed by granuloma macrophages in WT mice but not in IL-4Ralpha -/mice, as determined by antibody staining (Linehan et al, 2003). This indicates that the
alternate response was dependent on Th2-type cytokines, as knocking down the receptor
for Th2 cytokines also stopped expression of the mannose receptor, the then-prototypical
marker for alternate activation. Later experiments have shown that the patterns of
activation shown with the Th2-type cytokines are also dependent on the transcription
factor STAT6, indicating that there were transcriptional changes associated with an
alternative activation. This was shown when CD4+ T cells transferred from H. polygyrusprimed mice induced alternatively activated macrophages in wild-type (d,e) but not Stat6/- recipients (Anthony et al., 2006).
These observations have led to the understanding that “alternate activation” is not
simply a deactivation of macrophages caused by Th2-type cytokines, but is an alternate
pattern of activation, a different phenotype designed to accomplish separate goals than a
classically activated macrophage. “Classically activated”, or M1 macrophages display
characteristics consistent with a Th1-type phenotype, including chronic inflammation,
recruitment of other immune system cells to the affected area, and tissue damage,
7

whereas “alternatively activated” or M2 macrophages resolve inflammation and facilitate
wound healing.

Fig. 6: The products of the M1 and M2 phenotypes of macrophages dictates their roles: outputting NO and citrulline
makes M1 macrophages killers, while M2 macrophages are anti-inflammatory “healers”. Adapted from Sly et al., 2007

Alternatively activated, or M2 macrophages, are activated differently than M1
macrophages. For instance, differentiation of alternatively activated macrophages does
not require any priming. IL-4 (Stein et al., 1992) or IL-13 (Doherty et al., 1993) are
sufficient to cause the differentiation. Once these factors are bound to their receptors,
fluid-phase pinocytosis of soluble antigen may take place. (Brombacher, 2000, Conner
and Schmid, 2003, Montaner et al., 1999) The next step is somewhat like the classical
activation, wherein soluble antigen is coupled with MHC class II molecules and the
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antigen/MHCII complexes are subsequently displayed to T cells, along with costimulatory B7 family members. (Harding et al., 2003)

Fig. 7: The process of antigen presentation in macrophages, from uptake and endocytosis to degradation of the invading
molecule and presentation of the peptide to T cells. The macrophage also releases proinflammatory cytokines. Adapted
from Nicchitta, 2003

Also, similar to the classically activated macrophage, changes are seen in the
alternatively activated macrophage’s cellular morphology and secreted molecules as a
result of appropriate stimulation. These macrophages release chemokines which attract
leukocytes, including pulmonary and activation-regulated chemokine (PARC/CCL18)
(Kodelja et al., 1998, Goerdt et al., 1999) Macrophage-derived chemokine
(MDC/CCL22) (Andrew et al., 1998, Imai et al., 1999) and TARC/CCL17. (Imai et al.,
1999) Where the real differences between classical and alternative activation become
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evident, though is when anti-inflammatory cytokines such as IL-1ra/IL-1F3, (Mantovani
et al., 2001) Ym1, Ym2, resistin-like molecule A (RELMa), (Raes et al., 2002, Loke et
al., 2002) IL-10, (Mosser, 2003) and TGF-β are released. In addition to being an antiinflammatory mediator, TGF-β also indirectly promotes ECM accumulation by inducing
nearby fibroblasts to produce ECM components. (Song et al., 2000) ECM accumulation
is aided by the M2 macrophage itself, which secretes the ECM components Fibronectin
and bIG-H3, (Gratchev et al., 2001) Trans-glutaminase (a ECM cross-linking enzyme),
(Haroon et al., 1999) and Osteopontin, which functions by facilitating cell adhesion to the
ECM. (Murry et al., 1994)

In addition, alternatively activated macrophages upregulate expression of the
enzyme Arginase I, which is involved in proline as well as polyamine biosynthesis.
Proline promotes ECM construction while polyamines are involved in cell
proliferation.(Hesse et al., 2001) Other factors secreted by the alternatively activated
macrophage that promote cell proliferation include platelet-derived growth factor
(PDGF), insulin-like grown factor (IGF), and transforming-growth factor beta (TGF-β).
(Song et al., 2000, Cao et al., 2000) As well as promoting cell profileration, these factors
participate in angiogenesis, along with fibroblast growth factor (FGF basic), TGF-α, and
vascular-endothelial growth factor (VEGF). (Cao et al., 2000, Sunderkotter et al., 1991)

Taken as a whole, the profile of the molecules secreted by the alternatively
activated macrophage contribute to an immune response characterized by a lessening of
10

inflammation and promotion of wound repair. The response can be characterized as antiinflammatory, proliferative, fibrotic, and angiogenic. In keeping with its profile as similar
to that of a Th2 reponse, M2 macrophages are also efficient at combating parasitic
infections, like schistosomiasis and filiariasis. While the alternatively activated
macrophage is beneficial for the body, and for wound repairing in this way, it is also true
that M2 macrophages are not as effective at eliciting a strong immune Th1 immune
response as M1 macrophages (by design), and by themselves they have been implicated
in several pathologies, the most prominent of which are allergy and asthma (Duffield,
2003, Gordon, 2003)

Fig. 8: Parasites, by activating receptors like the chitin receptor on macrophages, induce a Th2 differentation. Adapted
from Akira, 2010

One of the key discoveries in the current distinction between M1 and M2
macrophages was the discovery that they metabolize the amino acid arginine differently.

11

Macrophages take up arginine from the surrounding environment by cationic amino acid
transporters (cat) embedded in their plasma membrane (Schapria et al., 1998). Once taken
into the cytosol, the cell has two basic options for metabolism of arginine – it can use the
nitric oxide (NO) pathway, which is what happens if the cell is in the M1 phase, or the
arginase pathway, used by M2 macrophages. These pathways produce different results –
the NO pathway produces NO and L-cituline, while the arginase pathway produces urea
and L-orthinine (Mills, 2001). This branching pathway, in which one phenotype
metabolizes arginine through one pathway, and the other phenotype through another,
generates a number of biological molecules which are unique to each pathway – thus
making good markers for the phenotypic state of the macrophage.
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Fig. 9: NOS2 and ARG1 are divergent, non-overlapping pathways of arginine metabolism. Adapted from Bronte and
Zanovello, 2005

The NO pathway uses inducible nitric oxide synthease (iNOS) in the generation
of nitric oxide. This pathway is upregulated by Th1 cytokines, especially IFN- γ and
TNFα. Because of this, the NO pathway is also present in M1 or classically activated
macrophages (Bogdan, 2001). iNOS is expressed constantly during the time a
macrophage spends in the M1 phenotype, so massive amounts of NO can accumulate, up
to 1000 times the levels of NO present in unstimulated, or M0 macrophages (Bogdan,
2001). NO inhibits cell replication (Nathan et al, 1991) and inhibits mitochondrial
respiration. NO also triggers apoptosis (Albina et al, 1993; Saio et. Al, 2001).
Additionally, NO can interact with superoxide to create peroxynitrite. Superoxide is an
oxygen radical also generated by macrophages. While in some cases superoxide can
increase the cytotoxic effects of M1 macrophages, it may inhibit NO toxicity (Bautista
and Spitzer, 1994), – an effect which can be reversed by the production of superoxide
dismutase (Tohyama et al., 1996).
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Fig. 10: The signaling pathway of iNOS releases toxic NO, and is mediated by Jak/Stat signaling. Adapted from
Howard et al., 2010

Instead of the NO pathway, M2 macrophages use the arginase pathway. While
macrophages contain both arginase I and arginase II, arginase I is the enzyme used in the
NO pathway. It is present in the cytosol (arginase II is present in the mitochondria).
Arginase I (ARG1) expression is upregulated in response to Th2 cytokines: IL-4, IL-13,
TFGβ, and IL-10 (Morris et. Al, 1998). Arginase I converts arginine to orthinine, which
is then converted to polyamines. Polyamines are required for DNA replication, so their
production favors cell proliferation (Pegg, 1988). This is part of the reason that the
arginase pathway seems to favor tumor proliferation. The arginase pathway also favors
the proliferation of lymphocytes (Bowlin et al., 1987)

14

Fig 11: As shown here, the Arginase pathway produces Orthinine as one of its products, which is a building block for
polyamines, promoting cell growth and hence tumor proliferation. Adapted from Caldwell, 2010.

These same properties also make the M2 macrophages ideal for tissue and nerve
regrowth, and may help in wound healing after nerve damage (Kigerl, 2009).

While the M1/M2 nomenclature will be used in the scope of this paper, it is
important to note that there are certain shortcomings to the nomenclature. Some
transcriptional studies (Biswas et al., 2006; Ghassabeh et al., 2002) have shown that some
populations of macrophages are intermediates between the two phenotypes, and have
transcriptional profiles that don’t match a simple definition as M1 or M2 macrophages –
they have characteristics of each. It is not currently known if these macrophages represent
other discrete phenotypes, or if there exists a gradient of M1-like and M2-like
characteristics, which a macrophage might express many combinations of. One solution
15

to this problem taken by Mantovani et al. (2004), is to further divide M2 macrophages. In
this system, M1 refers to macrophages which are activated by LPS, IFNgamma, and other
Th1 type cytokines, and have the following profile: IL-10low, IL-12high, IL-23high, and
are good antigen-presenting cells. They produce high levels of NO and other reactive
oxygen intermediates. In contrast to this, the M2 category is a catchall for “not M1”,
including macrophages that have a profile of IL-12low, IL-10high, with enhanced tissue
remodeling properties. M2 macrophages are further divided into M2a and M2b. M2a
macrophages are activated by IL-4 or IL-13, and M2b macrophages are activated by IL10 or glucocorticoid hormones (Mantovani et al., 2004). Future genomic and proteomic
analysis may clarify the various phenotypic states that macrophages can exist in. For this
paper, M1 indicates a more aggressive, proinflammatory, proliferative, pro-apoptosis
phenotype, differentiated by the presence of iNOS, and M2 indicates an antiinflammatory, tissue regeneration-promoting phenotype differentiated by the expression
of the arginase gene (Arg1). It is known that iNOS levels are very low in macrophages in
the M2 phenotype, while Arg1 levels are very low in M1 macrophages. This is intuitively
sensible, as these represent divergent paths in the metabolism of arginine, and are
unlikely to coexist in large quantity. Macrophages that shift from an M1 phenotype to an
M2a phenotype experience an increase in arginase expression that is concomitant with
their reduction in inducible nitric oxide synthase (iNOS) expression (Munder et al., 1998,
Munder et al., 1999).
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Figure 12: The NO produced by the M1 pathway (iNOS) leads to parasite killing, while the arginase 1 pathway shown
in the middle leads to spermine and parasite proliferation. Adapted from Fouce et al., 2012

Both the M1 and M2 populations of macrophages can be shown to have
environments in which they are greatly helpful, and microenvironments in which their
presence is either less helpful or actively harmful. M1 macrophages are important both in
fighting infection and in the reduction and destruction of tumors. Because of their proinflammatory, immune cell-recruiting cytokines, and because of their proliferation and
activation of the rest of the immune system, M1 macrophages are associated with
increased odds of survival during cancer, and in general anti-tumor activities (Ma et al.,
2010). Additionally, due to the anti-microbial properties of M1 macrophages, the
common immunological response during acute infection (by bacteria or viruses, not
parasites) is to polarize macrophages towards an M1 response
17

Fig 13: IFN-gamma, TNF, LPS polarize towards the M1 phenotype, while parasites, specigically Chitin, or IL-4
polarizes macrophages towards the M2 phenotype. Adapted from Satoh et al., 2010

As an example, during infection with Listeria monocytogenes, which causes
disease in pregnant women and the immunocompromised, the body induces the M1
phenotype in macrophages. The pro-phagocytic cytokines act to prevent bacterial
phagosome escape. This allows for increased intracellular killing of bacteria both in vitro
and in vivo (Shaughnessy and Swanson, 2007). Studies done using mice that do not have
IFN-γ and TNF and their receptors (two markers of M1 polarization) die from L.
monocytogenes infection (Pfeffer et al., 1993). Similarly, Salmonella typhi, the agent of
typhoid fever, and Salmonella typhimurium, a gastroenteritis agent, induce the M1
polarization of human and murine macrophages, and this induction is associated with the
control of the infection (Benoit and Mege, 2008).
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M2 macrophages show the most positive effects when mediating wound healing
and nerve regrowth. M2 macrophages aid in tissue healing, nerve regrowth, and
angiogenesis by releasing cytokines which promote angiogenesis and matrix remodeling
while simultaneously suppressing destructive immunity (Sica et al., 2006). In one
exploratory study, it was found that in mice who received an electromechanical contusion
in their central nervous system (CNS), M2 macrophages promoted nerve regrowth with
axons regrowing to more than two times the length of axons in tissues where M1
macrophages predominated. It was hypothesized that, since the population of M1
macrophages persists for far longer than the M2 population, which lasts about 3-7 days,
M2 macrophages were responsible for wound healing and nerve re-growth in the
damaged region, and M1 macrophages might protect the area from secondary infection.
The authors suggested that understanding the diverse roles that M1 and M2 macrophages
played in the course of CNS wound healing would be informative. They also suggested
that the ability to modulate the phenotypic profiles of the macrophages involved in the
wound after nerve damage might be highly valuable in producing more desirable
outcomes (Kirgerl et al., 2009)
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Fig 14:Through upregulation of TNF-alpha and infiltration of macrophages into wound tissue, Keratinocyotes and
Fibroplasts are stimulated through the TNFR1 and facilitate wound healing. Adapted from Lia et al., 2009

The subject of macrophage polarization is a complex one, and not everything is
known about the ways in which macrophages become polarized to one phenotype
or another. Nonetheless, some generalizations can be drawn. It is known that
macrophages become polarized to the M1, or classically activated phenotype,
after stimulation with LPS or IFN-γ or both, which induces TNF-α, and M2 or
alternatively activated macrophages were produced after stimulation with IL-4
and IL-13 (Gordon, 2003). It is also known that LPS + IL-1β, IC + IL-1ra, TGFβ,
and IL-10 can stimulate M2 macrophages (Martinez et al., 2008), and other
20

proinflammatory cytokines such as IFNs, IL-1, IL-2, and hypoxia can induce M1
macrophages polarization. Obviously, then, there are a diverse set of pathways
that can lead to their activation (Melillo, 1995, Kleinart et al., 2003)

Fig. 15: In general, Th1 cytokines, LPS, and IFN-gamma stimulate the M1 phenotype, responsible for inflammation
and further stimulation of the immune system, while Th2 cytokines stimulate the repair-centered M2. Adapted from
Sica et al., 2006

Furthermore, macrophage phenotype is plastic – macrophages can be polarized to
the M2 phenotype from the M1 phenotype, vice versa, and will revert to an unpolarized
M0 phenotype in the absence of stimulus to one or the other phenotype (Devaraj and
Jialal, 2011, Mantovani et al, 2002). To convert one macrophage phenotype to the other
simply requires that the macrophage be stimulated with the appropriate polarizing
signals, and taken out of the environment which initially polarized it to the opposite
phenotype (Kirgerl et al., 2009).
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Because understanding macrophage polarization might give insight into disease
progression and wound healing, because there are selectable markers that indicate the
state of the macrophage phenotype (iNOS for M1, ARG1 for M2), and because all the
current tests for macrophage phenotype rely on lengthy detection of proteins through
immunological assay (i.e. ELISA tests, flow cytometry, western blots), it is desirable to
develop a quantitative, real-time test for the state of the macrophage using the markers
mentioned above, which can be performed on live cells.

MATERIALS AND METHODS

The goal of this project is to create a macrophage cell line which allows
visualization of macrophage polarity in real-time on live cells. This is to be done by the
creation of a plasmid which detects transcription of proteins indicating one or the other
phenotypic state, coupled to a reporter

Fig 16: A standard plasmid has an ori with multiple restriction sites and selection marker for detection. Adapted from
Hoesl, 2011.
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The reporter for this system was to be either green or red fluorescent protein (GFP
and RFP, respectively). GFP and RFP are relatively well-characterized molecules that
fluoresce either a green or a red color when excited with a different UV light wavelength
(Inouye and Tsuji, 1994). Their expression is non-toxic to cells, easily detected through
non-lethal doses of UV radiation, and able to be quantified using a spectrophotometer
(Chalfie et al., 1994).
In addition to the reporter system, a means of detecting the phenotypic state of
macrophages is needed for this plasmid. As mentioned above, the levels of iNOS and
ARG1 are inversely related, with iNOS being high and ARG low in M1 macrophages,
and vice versa. This is because they play opposite roles in the metabolism of arginine,
with the MO pathway being used in M1 macrophages, and the arginase pathway in M2.
The promoter regions for the iNOS and ARG1 genes, therefore, will be used in the
construction of the plasmid. Fortunately, botch of these promoters have previously been
isolated, the ARG1 plasmid by Pauleau et al (2004),
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Fig 17, the Arg1 promoter plasmid – note the firefly luciferase for identification, and the MhuI and XhoI sites for
restriction digests. Adapted from Pauleau, 2004

who found that both the promoter region and an enhancer ~kb upstream from the
promoter start site were required in a plasmid for stable and significant activation when
the host cell promotes ARG1 transcription. The iNOS plasmid was found to be sufficient
without enhancer regions to be activated on a plasmid when the host cell activated iNOS
transcription (Lowenstein et al., 1993)
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Fig 18: The iNOS promoter plasmid also includes an upstream enhancer region. Adapted from Andresen et al., 2004.

Both plasmids were graciously provided by the respective labs that developed them.
Once the plasmids were obtained, a vector and E. coli line were chosen. This
project will use the pBluescript SK+ plasmid vector (PBSSK+) for bacterial expression,
both for its stable expression in a variety of bacteria, and also for its MCS, which
contains the appropriate restriction sites. The PBSSK+ plasmid is capable of holding both
the ARG1 and iNOS promoter. Appropriate cloning sites must be chosen – ideal sites
should be found on either end of the promoter section of the promoter plasmid and on the
MCS of the pBSSK+ plasmid for proper insertion of the promoter into the bacterial
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expression vector. Additionally, an appropriate host strain of E. coli must be selected.
Stbl3 E. coli were chosen for this project, because they proved able to uptake the plasmid
and were able to be grown on a miniprep afterwards.

Following selection of restriction sites, and E. coli population, a concentration of
the appropriate promoter plasmid is transfected into the stbl3 E. coli. This is grown in
culture overnight. The culture is isolated, and the plasmid DNA is isolated through a
miniprep. This DNA is subjected to a restriction digest with the predetermined restriction
enzymes, which are then run in an electrophoresis gel. Assuming the correct size bands
are found, which indicates a successful restriction digest, the E. coli is grown up and the
plasmid DNA isolated in a maxiprep (which gives much greater plasmid yield as
compared to the miniprep).
FUTURE WORK

After growing the E. coli and harvesting the plasmid DNA in a maxiprep, the DNA is
then run again on a gel. Assuming the correct size bands are found, the DNA will be
isolated from the gel and added to a solution of PBSSK+ plasmid which will be cut with
the appropriate restriction enzymes to encourage uptake on plasmid, along with ligase.
This ligation mix will be incubated, and added to a culture of E. coli which will be
subjected to heat shock. If successful, this procedure will introduce the PBSSK+
promoter into the culture of E. coli. This will yield a plasmid which confers bacterial
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ampicillin resistance to the E. coli, and will become activated along with the appropriate
protein (iNOS or ARG1) because of the promoter element. The procedure to insert the
promoter section into the plasmid will then be repeated to add GFP or RFP to the 5’ end
of the promoter plasmid on the plasmid, meaning that activation of the promoter element
on the plasmid will yield GFP or RFP.

Fig. 19: The final shape of the PBSSK+ plasmid

Meanwhile, a culture of the macrophages (in this case, RAW 277.97
macrophages) are transfected with a PBSSK+ plasmid with the GFP or RFP sequences to
be used in the experiment attached to a constitutive promoter, and one with GFP and RFP
with no attached promoter. These macrophages are examined under a fluorescent
microscope, and used as baselines for total expression and non-expression of the marker.
These endpoints will be used to evaluate the strength of the expression of the GFP and
RFP in the plasmid with the promoter element. The E. coli transformed with the promoter
plasmid + GFP or RFP are selected by growing on amp+ media. These E. coli are grown

27

overnight in amp+ broth followed by a miniprep experiment to determine that the
plasmid has been inserted correctly, in the proper orientation in the E. coli. These
plasmids containing the promoter of interest and either GFP or RFP are then transfected
into the macrophage cell line with lipofectamine, which increases the efficiency of
transfection. This yields the cell line of interest – a culture of macrophages that will
fluoresce green or red when the iNOS or ARG1 is promoted in culture. Next, the
macrophages which have successfully taken up the plasmid must be isolated and cloned.
This involves isolating macrophages that fluoresce under appropriate UV radiation, and
clonally growing them. The copy number of the plasmids in these macrophages must now
be determined. This can be performed by Southern blot, by comparing the signal intensity
of the unknown copy number to a known copy number. This process should then be
repeated using the other promoter/reporter, transforming the promoter + reporter into the
macrophages that already contain one such construct. The final macrophage will express
GFP if one promoter is activated, and RFP if another is activated. This plasmid system is
then tested by incubating these macrophages with cytokines known to polarize the
macrophage to one phenotype or another (LPS and IFN-γ for M1, IL-4 and IL-10 for
M2), and the fluorescent patterns are observed under a fluorescent microscope.
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POSSIBLE PROBLEMS/SOLUTIONS

There are a few foreseeable problems that could arise during the construction of
these transgenic macrophages. First, and most potentially troublesome, is the difficulty of
cloning the macrophages after isolation based on GFP expression. Macrophages can be
difficult to cultivate following isolation, as individual macrophage cells frequently have
trouble expanding, and die, even in media with sufficient nutrients. This could be solved,
if necessary, by using a macrophage line which has been shown to be able to clonally
expand after the uptake of a transgene, such as mouse alveolar macrophages (Joshi et al.,
2008). Additionally, the reporters might have to be altered. There is some spectral
overlap between the range of UV wavelengths that GFP and RFP respond to, and there
could potentially be confusion in interpreting fluorescence. If this is a problem, markers
with excitation spectra further from GFP, such as brilliant violet or aqua.

FUTURE IMPLICATIONS

Once the system is in place, the macrophages can be given any number of
challenges – infection with foreign agents, bacterial or viral, addition of cytokines whose
polarizing effects on macrophages are unknown, polarization profiles after being affected
by a number of different cytokines. Of initial interest would be visualizing the
polarization of macrophages in the presence of herpes simplex virus – it is possible that
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due to their persistence in cells long-term, they might act to induce an M2 polarization of
macrophages. Likewise, both acute and long-term bacterial infectious agents could be
investigated, to see if different ones induce different polarization profiles in
macrophages. It would also be interesting to see if different classes of infectious agents –
bacteria, viruses, and parasites, tend to induce different profiles, especially because
parasites are mostly greatly affected by th2 mechanisms, it would be interesting to see if
M2 macrophages predominate, and over what time periods they predominate, in parasitic
infection.
The real-time nature of the expression of GFP and RFP means that the time a cell
remains polarized, and the speed with which it becomes depolarized, could be explored in
much greater detail than has yet been observed. Additionally, using this system as a
model, promoters for other proteins of interest during macrophage polarization could be
detected using expression of GFP and RFP, as an example, the SOCS pathway could be
investigated in some detail. It is also possible that the polarization of macrophages in
vivo could be investigated. In this situation, promonocytes could be isolated from murine
bone marrow, and transformed with the promoter/reporter system described above. If reintroduced into the mouse they were taken from, these cells could produce macrophages
which expressed the promoter/reporter construct. While GFP/RFP would be inappropriate
for this task, noninvasive bioluminescent imaging with luciferase has been shown to be
able to image selected cells in whole animals. This could show real-time images of the
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progression of macrophage polarization in whole animals during the course of injury or
infection (Mezzanotte et al., 2011).
The use plasmids to solve other biological problem is expanding on multiple
fronts. One other possibility for recombinant DNA is the construction of computational
plasmids. In computational plasmids, assume that P is a plasmid, k is a positive integer
and s1 to sk are k pairwise non-overlapping subsegments of P. Also assume that for each
i, the nucleotide sequence of si is unique within the plasmid P. These unique segments
chosen in this way are ‘stations’ of the plasmid. Once this setup is developed, a
computation is begun. It begins with a test tube of or buffer that contains many identical
k-station plasmids. The plasmids are modified in such a way as to be readable later, and
only modified at the stations. Because of this binary modification, each station on the
plasmid is either modified or unmodified, which can be thought of as one of the bits – a 1
or a 0

Fig. 20: By dividing the strand of DNA into “stations” with specific restriction enzymes, operations can be performed
independently on separate stations and the final results can be computed by examining stations later. Adapted from
Head et al., 2000.
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When conceived of in this way, each station is similar to a k-bit data register in a
computer. The “memory” in this kind of computing is simply the totality of the system –
the water plus the plasmid content. This is done because water helps with rapid
partitioning of memory into subsets. This can be accomplished through stirring or
diffusion. It makes the assumption that each of the members of such a partition contains
the same variety of molecules. Different, separate members of the partition can be
modified in different ways and brought back later into a single test tube. Once brought
back together, the final “solution”, or computational answer, is read from the solution –
the water plus plasmid. Many separate methods for modifying the plasmid might exist,
but cutting and pasting sequences is a valid way to modify them. In this way, the speed
and accuracy of biological processes can be brought to bear to solve complex
mathematical problems (Head et al., 2000).
Another problem that can be solved with plasmids, in this case larger-scale ones,
is to create a DNA library. In a DNA library, a collection of DNA fragments that come
from one organism, and are stored in another, often a bacterium, are collected. This is
first achieved by extracting and purifying DNA from human cells. This collected DNA is
likely made of extremely long strands of DNA, so it is digested with restriction enzymes.
Because DNA is so large, each restriction enzyme is likely to cut the DNA in multiple
places. Thousands of fragments are thus generated, each of which might contain one or
more genes. Each fragment is then inserted into a plasmid vector – this can be done
because researchers know the profile of restriction enzymes they used to create the
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fragments, thus they know the profiles of the sticky ends of the pieces of DNA, and can
cut plasmid vectors with the matching restriction enzymes. The fragments are then put
into E. coli, which is grown to large numbers, creating many copies of each fragment of
DNA

Fig 21. Construction of a plasmid-based DNA library involves cutting the DNA from a cell into piecies, ligating them
into the vector, and storing the vector in bacteria – the process is similar for a cDNA library, but mRNA is converted
through reverse transcriptase into cDNA which is then inserted into the vectors. Adapted from Winning, 2012.

The fragments of DNA can then be isolated and studied, or the researcher can further
isolate the particular genes they are interested in for further study. (Cain et al., 2006)
There has been a great amount of interest lately in recombinant DNA and
molecular biology – one source for models of molecular and sensing biology is the
international genetically engineered machine (iGem) competition. This competition, for
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undergraduate biology students, involves being a standard set of biological building
blocks (standardized plasmids, promoters, reporting systems, etc.) taken from the registry
of standard biological parts. These parts are combined to create biological models that
accomplish creative and useful tasks (igem.org). part of the inspiration for this project
was taken from a project in which E. coli was modified to detect environmental mercury
through production of GFP. This was accomplished through a plasmid that detected
changes in the host cell commonly associated with the cell responding to environmental
mercury, and designed a plasmid that would express green fluorescent protein when this
happened in the cell (http://2012hs.igem.org/Team:WarrenCentral_WCC_IN).
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Career
Focus___________________________________________________________________
Microbiologist and computer scientist. Lab experience, both with self-directed
and team-based research. Wet lab experience includes ELISA, Western and
Southern blots, gel electrophoresis, PCR,
culturing techniques, plasmid transformation, vacuum filtration, flow cytometry,
titration. Computing experience includes proficiency in java, C++, ruby, and perl.
Designed programs
to interface with online databases, match genetic profiles by similarity, and
record results.
Core
Qualifications____________________________________________________________
-

Knowledge of in vitro culture and immunohistochemistry techniques, such as
sterile technique, culturing and colony isolation, ELISA, western and southern
blots, plasmid transfection, antibody staining, confocal microscopy, and gel
electrophoresis.

-

Ability to construct plasmids by selecting appropriate genes, promoters, and
vector systems.
Experience with maxi and mini-preps, transfection, transformation, and
plasmid insertion by
viral vector or lipofectamine.

-

Excellent communication, documentation, and presentation skills.
Experience managing ordering for a lab, documentation of procedures and
techniques, and management of lab stores. Ability to communicate and work
effectively with a team.

Employment
Summary___________________________________________________________
05/2011 – Present

Forensic Bioinformatics Dayton, OH
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Genetic analyst/programmer
06/2010 – 08/2010

Wright State University Dayton, OH
Clinical Laboratory Science graduate teaching assistant and

inventory
management
03/2010 – 05/2010

Wright State University Dayton, OH
Microbiology Graduate Teaching Assistant

10/2008 – 06/2009

Wheaton College Wheaton, IL
Undergraduate Researcher, biology/microbiology

08/2004 – 05/2009

Wheaton College Wheaton IL
Wheaton ResNet, Senior Call Center Tech Support

06/2008 – 08/2008

IDCAST, Dayton OH
Researcher

06/2007 – 08/2007

Yellow Springs Instruments, Yellow Springs, OH
Research Assistant

Education_______________________________________________________________
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(Fall) expected graduation date
Microbiology MS
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Microbiology BS
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